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Abstract
Hearing loss and individual differences in normal hearing both have a substantial genetic basis. Although many new genes
contributing to deafness have been identified, very little is knownabout genes/variantsmodulating the normal range of hearing
ability. To fill this gap, we performed a two-stage meta-analysis on hearing thresholds (tested at 0.25, 0.5, 1, 2, 4, 8 kHz) and on
pure-tone averages (low-, medium- and high-frequency thresholds grouped) in several isolated populations from Italy and
Central Asia (total N = 2636). Here, we detected two genome-wide significant loci close to PCDH20 and SLC28A3 (top hits:
rs78043697, P = 4.71E−10 and rs7032430, P = 2.39E−09, respectively). For both loci, we sought replication in two independent
cohorts: B58C from the UK (N = 5892) and FITSA from Finland (N = 270). Both loci were successfully replicated at a nominal level
of significance (P < 0.05). In order to confirm our quantitative findings, we carried out RT-PCR and reported RNA-Seq data, which
showed that both genes are expressed in mouse inner ear, especially in hair cells, further suggesting them as good candidates
formodulatory genes in the auditory system. Sequencing data revealed no functional variants in the coding region of PCDH20 or
SLC28A3, suggesting that variation in regulatory sequences may affect expression. Overall, these results contribute to a better
understanding of the complex mechanisms underlying human hearing function.
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Introduction
The identification of new genes involved in modulating the
auditory systemwill provide important insight into the complex
mechanisms and the extensive heterogeneity of the hearing
process. Although much effort has been made to search for
genes involved in hearing function and loss, the molecular
basis of normal hearing function is still largely unknown. For
many complex traits, there is evidence that rare Mendelian
mutations, copy number variation and rare variants contribute
to a proportion of cases. More than 140 loci associated with non-
syndromic hearing loss have now been mapped, and ∼80 genes
have been identified in humans (http://hereditaryhearingloss.
org/). So far, very few genes have been described as possibly in-
volved in complex phenotypes (e.g. normal hearing function
and age-related hearing loss). Quite recently, genome-wide as-
sociation studies (GWAS) have produced a list of SNPs/genes
showing association with these traits. In particular, a GWAS
identified significant associations between age-related hearing
impairment and a glutamate receptor GRM7 in European popu-
lations (1), followed by a replication in a European American
population (2). In our previous GWAS meta-analysis, using
European isolated populations, we detected several suggestive
associations (3). A later follow-up of these results highlighted
12 genes, which were replicated and validated at the expression
level (4), including another glutamate receptor named GRM8.
Furthermore, a recent GWAS meta-analysis identified SIK3 (5),
a member of the salt-inducible kinase family known to be
involved in the inner ear. In a candidate gene study, the estro-
gen-related receptor gammawas suggested as a potential player
in themaintenance of hearing in both humans (mainly females)
and mice (6).
Considering recent findings and the extremely intricate me-
chanisms underlying the auditory process, we reasoned that
GWAS might help in the detection of new genes involved in the
variability of the hearing process; such genes may play a role in
defining penetrance, progression, expressivity, pleiotropy and
age of onset of hearing loss. We therefore performed a GWAS
meta-analysis based on 1000 Genomes imputation data in sev-
eral Italian isolated populations and identified 2 statistically sig-
nificant candidates for modulating normal hearing function.
These hits were then replicated in different communities located
along the Silk Road and in two independent cohorts fromUK and
Finland.
Results
Statistical association
The first-stage meta-analysis was performed in 2155 subjects
from 4 Italian cohorts, testing 9 hearing measurements (6 single
frequencies and 3 PTAs). Therewere no signs of population strati-
fication (all lambda coefficients ≤ 1.01), and a total of 223 SNPs
reached a P-value of < 1e−06 (Supplementary Material,
Table S1). These 223 SNPs were further analyzed by combining
data from a completely independent cohort of isolated commu-
nities (Silk Road cohort, N = 481), resulting in a total sample size
of 2636. In the combined analysis, 35 out of the 223 SNPs were re-
plicated on the same traits and genetic models, reaching a gen-
ome-wide significant P-value of <5e−08 (Supplementary
Material, Table S2). Among the 35 significant SNPs, 32 were lo-
cated within 1 large locus on 13q21.31 (chr13:62382925–
chr13:62520492 according to build 37) and located close to
PCDH20 (Fig. 1). The top SNP in this region is rs78043697-C,
Figure 1. Locus-zoom plot for chromosome 13 locus. The plot shows the locus on chromosome 13 associated with normal hearing functions measured at 2 kHz,
highlighting the top SNP rs78043697 and several other significant SNPs in the same region being in high linkage disequilibrium. The results plotted were obtained
with a two-stage meta-analysis, focusing on Italian isolates first and then including the communities from the Silk Road. The y-axis shows −log10 of the P-values
obtained from the complete meta-analysis of the 2 kHz hearing threshold. The closest gene PCDH20 is shown along the x-axis.
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which reached a P-value of 4.71E−10 on the 2 kHz trait under the
dominant model. Subjects homozygous for the non-effect allele
T (N = 1964) have a better hearing compared with the other
groups (N = 191), e.g. the difference between median values in
INGI-FVG was 3.7 dB (Fig. 2). The remaining SNPs are in very
high linkage disequilibriumwith the top SNP (r2 > 0.8), suggesting
that their observed effect was due to linkage disequilibriumwith
the top associated SNP. To verify this hypothesis, we reran the as-
sociation analysis in the INGI-FVG cohort, which showed the
strongest association among the samples included in the first-
stage meta-analysis (Fig. 3), conditioning on the top SNP
(rs78043697). As expected, no significant residual signal re-
mained (P-values > 0.05) (data not shown), suggesting that there
is only one independent signal in this locus. The phenotypic vari-
ance of the 2 kHz hearing explained by rs78043697-C was 1.8%.
The second highest SNP was rs7032430-A (P = 2.39E−09 and
P = 4.22E−09 for 0.5 kHz under additive and dominant models,
respectively) located on 9q21.32 and explaining 1.3% of the
phenotypic variance of the 0.5 kHz hearing. Subjects carrying
the effect allele A (N = 1007) have worse hearing compared
with those homozygous for the non-effect allele C (N = 1622),
by ∼1.6 dB in INGI-FVG (Fig. 4). Several SNPs in the same locus
show association with the same trait. Among these,
rs35664751-A, in high linkage disequilibrium (r2 > 0.6) with
the top SNP (rs7032430-A), reached genome-wide significance
(P-value = 1.42E−08) (Fig. 5). These SNPs lie close to several
genes: RMI1, HNRNPK, C9orf64, KIF27, GKAP1, UBQLN1 and
SLC28A3. Prioritization for follow-up studies was based on
known functions, belonging to the same gene family as known
hearing genes and distance from the associated SNP. Based on
these criteria, SLC28A3 emerged as the strongest candidate,
belonging to the ‘solute carriers family’ whose members are
already known to be involved in hearing.
Finally, rs2243805-A on 2q14.3, located within LIMS2 and
GPR17, reached a genome-wide significant P-value of 1.74E−08
at 4 kHz under the dominant model. As no additional evidence
of association was found in this region, this SNP was not further
studied.
Table 1 shows summary statistics for the above-mentioned
loci, whereas Table 2 displays imputation quality (IMPUTE2 info
score) across cohorts for the top SNPs. Supplementary Material,
Table S3 shows the results (P < 0.05) for the top SNPs across all
Figure 3. Forest plot for rs78043697. The figure shows the forest plot for the top
SNP associated with 2 kHz threshold on chromosome 13 after performing the
two-stage meta-analysis. The x-axis represents effect sizes (beta coefficients)
for trait residuals after sex, age and kinship adjustments. The strongest
association can be observed in the INGI-FVG cohort.
Figure 4. Boxplot for rs7032430. The figure displays boxplots for the 500 Hz
frequency divided by genotype groups for rs7032430 and adjusted by sex, age
and relatedness in our largest cohort (INGI-FVG). As shown in the figure, people
carrying the AA genotype have higher values and hence worse hearing function.
Figure 2. Boxplot for rs78043697. The figure displays boxplots for the 2 kHz
frequency trait divided by genotype groups for rs78043697 and adjusted by sex,
age and relatedness in our largest cohort (INGI-FVG). As the effect for this SNP
was observed under a dominant model, the heterozygote genotype TC and the
homozygote CC are shown together.
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the traits and genetic models. In particular, it can be observed
that associations are not limited to a single trait e.g. rs7032430-
A is associated (although not significantly) with all the low-
medium frequencies (0.25, 0.5, 1 kHz) and to the relative PTAL
and PTAM. This is probably due to a true SNP effect on this
range of frequencies but also reflects the correlation between the
traits. To further prove the validity of our findings, a replication
step was performed using the B58C cohort (N = 5892), with only
two traits available (1 and 4 kHz), and the Finnish Twin Study on
Ageing (FITSA) cohort (N = 270) from Finland. Among the 35
SNPs, 4 SNPs within the 13q21.31 locus were nominally replicated
(P < 0.05) at the 1 kHz frequency in the B58C cohort (Table 3). For
the 9q21.32 locus, the second best hit rs35664751-Awas also nom-
inally replicated (P = 0.02761) in the FITSA cohort (Table 3).
Sequencing analysis
The top genes located on chromosomes 13 and 9 (PCDH20 and
SLC28A3, respectively) were selected for further analyses. To in-
vestigate any functional genetic variants marked by the asso-
ciated tag SNPs (rs78043697 for PCDH20 and rs7032430 for
SLC28A3) that contribute to the variation in this trait, a pool of
48 people (24 individuals for each gene) from the INGI-FVG cohort
Figure 5. Locus-zoomplot for chromosome 9 locus. The plot shows the locus on chromosome 9 associatedwith normal hearing functionmeasured at the 500 Hz aswell as
the genes within the region, including SLC28A3, the strongest candidate for hearing function. The results plotted were obtained with a two-stagemeta-analysis, focusing
on Italian isolates first and then including the communities from the Silk Road. The y-axis shows −log10 of the P-values obtained from the completemeta-analysis of the
500-Hz hearing threshold.
Table 1. Top SNPs for each locus resulting from the two-stepmeta-analysis on normal hearing function across six different frequencies (0.25, 0.5,
1, 2, 4 and 8 kHz) and under four genetic models (additive, recessive, dominant and overdominant), including only Italian cohorts in the first step
and then the Silk Road cohort in the second step
SNP Trait and model Chr Position EA AA N Beta SE beta Final P-value Dir N. pop. Orig. p
rs78043697 2 kHz dom 13 62467039 C T 2155 0.119997443 0.019266322 4.71E−10 +++?+ 4 1.83E−08
rs7032430 0.5 kHz add 9 86714002 A C 2629 0.035277526 0.00591061 2.39E−09 +++++ 5 1.27E−08
rs2243805 4 kHz dom 2 128407499 G A 2632 0.068598345 0.012170387 1.74E−08 +++++ 5 6.90E−08
rs35664751 0.5 kHz add 9 86717006 G A 2630 0.035460097 0.006253427 1.42E−08 +++++ 5 2.06E−07
SNP, single nucleotide polymorphism; add, additive; dom, dominant; Chr, chromosome; EA, effect allele; AA, alternative allele (non-effect allele); N, number of samples;
Beta, beta coefficients; SE, standard error; Dir, direction; +, positive effect; −, negative effect; ?, SNP not present/analyzed (cohorts: INGI-FVG, INGI-CARL, CILENTO,
TALANA, SR); N. pop, number of populations; Orig. p, original P-value (first-stage meta-analysis).
Table 2. Imputation quality score across cohorts for the two best hits
COHORT INFO rs78043697 INFO rs7032430
INGI-FVG 0.996 0.825
INGI-CARL 0.995 0.766
TALANA NA 0.795
CILENTO 0.994 0.737
SR 0.998 0.998
INFO, Imputation Info Score (IMPUTE2).
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were sequenced. Nine variants within the PCDH20 gene (3 in 3′
UTR; 5 exonic, of which 2 are synonymous, 2 non-synonymous
and 1 frameshift; and 1 in 5′UTR) and 42within SLC28A3 (1 down-
stream; 18 in 3′UTR; 5 exonic, of which 2 synonymous and 3 non-
synonymous; 14 intronic; and 4 in 5′ UTR) were identified.
However, none of the variants identified was associated with
the selected genotypes (i.e. tag SNPs). These findings further
strengthen the possible presence of variants in the regulatory
regions as expected for a quantitative trait. In this light, we con-
sulted RegulomeDB (http://regulomedb.org/), which is a database
annotating SNPs for known and predicted regulatory functions,
including data from ENCODE, but also other databases and pub-
lished literature (7). The outcome reported that several SNPs as-
sociated with PCDH20 and SLC28A3 were located in sites where
different transcription factors bind (Supplementary Material,
Table S4).
Gene expression analysis
In order to examine whether Pcdh20 and Slc28a3 are expressed in
themouse cochlea, we dissectedmouse inner ear tissues at post-
natal day 5 (P5) and performed RNA extraction for quantitative
RT-PCR (qRT-PCR) and semi-quantitative RT-PCR (sqRT-PCR)
(Fig. 6A and B). As positive controls we used both Myo7a and
Myo6, genes required for hair cell differentiation and associated
with hereditary deafness (8–10), which are abundantly expressed
in inner ear hair cells. Both Pcdh20 and Slc28a3 transcripts were
amplified by the qRT-PCR and sqRT-PCR, confirming that the
two genes are expressed in cochlea (Fig. 5). In particular, Pcdh20
showed lower expression than Myo6 and a 3-fold higher expres-
sion level than Myo7a (Fig. 6A). Slc28a3 displayed lower expres-
sion than these reference genes but was clearly visible on an
agarose gel after 30 cycles of sqRT-PCR (Fig. 6B).
RNA-Seq analysis of FACS-sorted cells in the developing
mouse cochlea and utricle demonstrated expression of both
genes from embryonic day E16 to postnatal day P7 (Fig. 7A and
B). Both are enriched in hair cells (GFP+; green) compared with
the surrounding cells (GFP−; purple). The overall fold change
(blue) shows that Pcdh20 is highly enriched in hair cells, and
Slc28a3 moderately enriched. Most striking is the strong expres-
sion in the utricle, especially at postnatal ages, but there is signifi-
cant expression in cochlear hair cells as well. In summary, both
genes are expressed in the mouse inner ear, with high enrich-
ment in vestibular hair cells and a less restrictive expression
pattern in the cochlea.
Discussion
Genes involved in hearing loss have been identified through
many different techniques, beginning with positional cloning
and linkage studies. In the past few years, high-throughput and
‘omics’ technologies, including GWAS and Next Generation Se-
quencing studies, have led to the identification of newgenes/mu-
tations in both Mendelian and complex forms of hearing loss.
Despite these successes, there is a need for a better understand-
ing of the molecular bases of hearing in complex forms, and as
a quantitative trait. In this field, identification of the association
of candidate genes at genome-wide statistically significant
P-values, replication in independent cohorts and demonstration
of expression in the inner ear can suggest a fundamental role for
the gene products in the auditory system (11).
Following this strategy, we performed a GWAS meta-analysis
followed by replication in several cohorts of European and
Central Asian ancestry.
This is the largest collaborative effort established on hearing
function so far, with a final sample size of 8707 samples and the
first GWAS approach to be reported on data imputed to the 1000
Genomes reference panel, resulting in a dense marker map and
increased statistical power and precision (12). Although some of
the cohorts used here were previously involved in GWAS meta-
analysis (3,5), the present study design was strictly focused on
Italian cohorts in the discovery phase and involved an overall in-
creased sample size. In this light, it was not surprising that previ-
ously reported results were not replicated in the present study.
Table 3. Association replication results in two independent cohorts from UK and Finland, replicating several SNPs from both candidate loci
(PCDH20 on chromosome 13 and SLC28A3 on chromosome 9) at a nominal significance level (P < 0.05)
SNP Trait and model EA AA N Beta SE beta P Cohort
rs111887296 1 kHz add T C 5892 −0.0109 0.005435 0.04495 B58C
rs113274536 1 kHz add T C 5892 −0.0111 0.005431 0.04072 B58C
rs75281867 1 kHz add C T 5892 −0.0110 0.005432 0.04215 B58C
rs77604362 1 kHz add T C 5892 −0.0110 0.005433 0.04239 B58C
rs35664751 0.5 kHz add G A 266 0.1017 0.046187 0.02761 FITSA
SNP, single nucleotide polymorphism; add, additive; EA, effect allele; AA, alternative allele; N, number of samples; Beta, beta coefficients; SE, standard error; P, P-value.
Figure 6. (A) qReal-time analysis of the selected genes (PCDH20, SLC28A3). (B)
Semi-quantitative RT-PCR. The plot shows expression for Pcdh20 and Slc28a3,
compared with Myo7a and Myo6 (A). The y-axis represents a scale whose unit is
the expression of the reference gene Myo7a. Pcdh20 displays a strong expression,
whereas Slc28a3 shows lower levels. Semi-quantitative RT-PCRdemonstrates that
both genes are expressed (B).
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The two-stage meta-analysis approach led to the discovery of
two genome-wide significant loci (close to PCDH20 and
SLC28A3). This approach was first proposed in order to minimize
the required sample size and genotyping without losing power
(13) and has been successfully applied in different studies
(14–16). It has been argued that this is an efficientwayof perform-
ing a single study and not a proper replication step (17). Thus, we
sought further nominal replication and we successfully repli-
cated both loci in independent cohorts, implying that, despite
genetic heterogeneity of the study populations, geneswith global
importance can be found.
The analysis of individual frequency thresholds as well as the
PTAs allowed us to comprehensively portray the normal hearing
function. Althoughmultiple phenotypes were tested, thesemea-
surements are not independent, thus reducing the concern about
multiple testing as already previously discussed (4). Statistical
power was also increased by testing four different genetic
models, a step of fundamental importance when sample size is
limited (18).
The top associated SNPs for the detected loci explained 1.3
and 1.8% of the phenotypic variance. These data show that the
associating variants had relatively large effect sizes when com-
pared with other known associations, such as height-associated
markers with variance explained ranging from 0.04 to 1.13% (19).
We acknowledge the possible limitation of the present study in
detecting lower effect variants owing to lack of power. In this
light, larger studies could be useful in the future to overcome
this problem.
The top genes identified in this study (PCDH20 and SLC28A3)
are both members of gene families already implicated in the
inner ear. PCDH20 belongs to the cadherin superfamily, whose
members have multiple roles in cellular adhesion (20,21) and
have been previously implicated in murine hearing loss as well
as in the human Usher syndrome (22). Although very little is
known about PCDH20, a phylogenetic grouping based on N-ter-
minal sequence suggests that has potential for trans-homotypic
and heterotypic interactions (21). We reported RNA-Seq and
qRT-PCR for validation of PCDH20 expression, finding it to be
expressed especially in the sensory hair cells. This gene is also
reported by the GENSAT atlas as expressed in the spiral ganglion
of the inner ear at E15.5 (http://www.gensat.org/index.html).
SLC28A3 is a member of the solute-carrier family and is
thought to concentrate nucleosides including cytidine, uridine,
adenosine and guanosine in a cell by coupling translocation of
two H+ or Na+ ions per nucleoside. Its apical location in absorp-
tive epithelia drives vectorial flux of nucleosides, which are es-
sential for nucleotide biosynthesis (23). Three other members
of the broad solute-carrier family are implicated in inherited
Figure 7. RNA-seq expression profiles for PCDH20 (A) and SLC28A3 (B). Histograms display the normalized number of reads in hair cells (green) and surrounding cells
(purple), in samples from the cochlea (C; dark colors) and utricle (U; light colors) at E16, P0, P4 and P7. The fold change (FC) representing the GFP+/GFP− counts ratio
and the multiple test adjusted false discovery rate by the Benjamini–Hochberg procedure are indicated.
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deafness (24–26). Both qRT-PCR and RNA-Seq showed clear ex-
pression of SLC28A3 in mouse cochlea and utricle. Moreover,
GTEx (http://www.gtexportal.org/) eQTL database revealed a sig-
nificant association between the top SNP rs78043697-C and
SLC28A3 expression in stomach tissue. These findings support
the hypothesis that rs78043697-C could affect the expression of
SLC28A3, although eQTL data for the inner ear tissue were not
available.
Although SLC28A3 is our strongest candidate, six other genes
(RMI1, HNRNPK, C9orf64, KIF27, GKAP1 and UBQLN1) located close
to the associated SNP on chromosome 9 were detected. For these
genes, a search of published material, existing public databases
on gene function, gene expression, related diseases, etc. did not
detect any possible link to hearing function.
No causal alleleswere identified in the sequencing of the coding
regions of PCDH20 and SLC28A3, supporting the involvement of
regulatory regions underlying these associations. Such a mechan-
ism is common inGWASstudies, and it hasbeen recentlyaddressed
by combining sequencing, epigenetic and transcription-factor data
sets (27), which could be a follow-up of the present study.
Finally, it should be noted that SLC28A3 is directly involved in
the metabolism of two drugs (anthracycline and gemcitabine)
and in the corresponding side effects/adverse reactions, which
also include hearing loss (28,29).
In conclusion, this study reports the discovery of two new
genes significantly associated with auditory function in humans
and hypothesizes a specific role in the sensory epithelium of the
utricle and cochlea. Although this should be confirmed with fur-
ther experiments, these results increase our knowledge of the
molecular basis of normal hearing function by identifying new
important candidates for further investigation.
Materials and Methods
Sample collection, preparation and genotyping
All studies had ethical approval obtained from the Institutional
Review Board of IRCCS—Burlo Garofolo, Trieste, Italy and other
involved institutions. Consent forms for clinical studies were
signed by each participant, and all research was conducted ac-
cording to ethics standards defined by the Helsinki declaration.
Detailed information about each cohort is shown in Table 4.
Italian isolated populations
Altogether 2155 subjects from 4 different cohorts (INGI-FVG, INGI-
CARL, Talana and Cilento) from several isolated communities
located in Northeast Italy, South Italy and Sardinia were recruited.
The collection of genotype and phenotype data followed the proto-
cols previously described (3). In brief, genomic DNAwas extracted
from blood, using a phenol-chloroform extraction procedure. DNA
samples were genotyped with Illumina 370-K and Affymetrix 500-
K chips.Quality controlfilterswere applied in eachcohort singularly
taking into account standard parameters, such as minor allele fre-
quency (MAF), call rate and Hardy–Weinberg equilibrium (Table 4).
Finally, all genotypes were checked to ensure that they were re-
ported with the coordinates of the 1000 Genomes Project (NCBI
Build 37) reference data and on the forward strand (30). These sam-
ples were previously used in GWAS studies (3,5) with another im-
putation version (HapMap CEU SNP set v22).
Silk Road (SR) cohort
We collected samples from 481 people from several rural com-
munities located along the Silk Road, during the Marco Polo Sci-
entific Expedition (31) (see Supplementary Material, Fig. S1). T
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Saliva samples were collected using the Oragene kit (DNA Geno-
tek, Inc.) andDNAextracted according to the supplier’s protocols.
As for the Italian isolates cohorts, SNP quality filters were applied
and coordinates aligned to the forward strand of the reference
(releases build 37) (30). These samples were previously used in
a GWAS (5) with another imputation version (HapMap CEU SNP
set v22).
1958 UK Birth Cohort (B58C)
The B58C and the collection of hearing data have been described
previously (6,32). In brief, participants were drawn up from 17 638
individuals born in England, Scotland andWaleswithin 1weekof
March 1958. Of the original cohort, 9377 members were revisited
by a research nurse for a biomedical follow-up in 2002–2004. The
hearing measure consisted of pure-tone audiometry at 1 and
4 kHz at age 44–45 years and was adjusted for sex, conductive
loss, hearing loss in childhood and nuisance variables (noise at
test, nurse performing test and audiometer used in test). Gen-
ome-wide data for the 1958BC were obtained through several
sub-studies, using them as population controls and genotyping
a total of 6099 individuals (for details, see http://www2.le.ac.uk/
projects/birthcohort/1958bc/available-resources/genetic). These
include the Welcome Trust Case Control Consortium study
(WTCCC1 and 2) (33), the Type 1 diabetes genetics consortium
(T1DGC) (34) and the GABRIEL Large-Scale Genome-Wide Associ-
ation Study of Asthma (35).
The Finnish Twin Study on Ageing
TheFITSA cohort includes 217 female twinpairs, aged63–76 years,
recruited inorder to investigate the contributionof genetic and en-
vironmental factors to the disablement process, and to investigate
the effects of ageing on several physiological and functional traits
(36). In the current study, a total of 270 subjects from196 twinpairs
withhearing phenotype, covariates andGWASdata availablewere
included in the analysis (91 subjects from 91 monozygotic pairs
and 179 subjects from 105 dizygotic pairs, of which 74 included
both co-twins and 31 included only one co-twin).
Imputation and filtering
In order to obtain a homogenous set ofmarkers among all the co-
horts and to increase the statistical power, genotypes were im-
puted following the same protocol in each cohort. In particular,
SHAPEIT2 (37) was used for the phasing step and IMPUTE2 for
the imputation step to the 1000-Genomes phase I v3 reference
set (38). After imputation, SNPs with MAF of <0.01 or imputation
quality score (Info) of <0.4 were excluded from the statistical
analyses. Table 4 shows the final number of SNPs analyzed
after imputation and filtering.
Audiometric evaluation
Audiometric tests and a careful clinical examination (psycho-
logical, neurological, cardiological evaluations, etc.) were carried
out for each individual of each cohort. Thresholds for six different
frequencies (0.25, 0.5, 1, 2, 4 and 8 kHz) were measured, with
exception of the B58C cohort, where only 1 and 4 kHz were avail-
able. Three pure-tone averages (PTAs) of air-conduction thresh-
olds were calculated: PTAL at low frequencies (0.25, 0.5 and
1 kHz), PTAM at middle frequencies (0.5, 1 and 2 kHz) and PTAH
at high frequencies (4 and 8 kHz). Overall, nine hearing traits
were analyzed. Moreover, to avoid non-genetic variations in the
hearing phenotype (e.g. unilateral hearing loss), the best hearing
ear was chosen. Familial forms of inherited hearing loss were
excluded from the study, as well as subjects affected by diabetes
or other systemic disorders producing hearing loss.
Association analysis
Genome-wide association studies were separately performed in
each cohort, testing individual hearing thresholds and the PTAs
(after adjustment for sex and age) in a linear mixed model in
order to account for genomic kinship. Four different geneticmod-
els were tested: additive, dominant, recessive and overdominant.
All the analyses were carried out using the GRAMMAR-Gamma
method as implemented in the GenABEL suit (39) for genotyped
SNPs andMixABEL (40) for imputed data.We did not consider any
P-value correction for the different genetic models tested be-
cause these are not four independent tests (41).
In order to increase the statistical power, a two-stage meta-
analysis approach was used. The first stage included only Italian
cohorts, using a fixed-effects meta-analysis with inverse vari-
ance weights as implemented in METAL software (42). Resulting
SNPswith P-value of <1e−06were carried out by joining the SRco-
hort and repeating the analysis (second stage). The final signifi-
cance level was set to 5e−08.
Finally, following the same analysis protocol, two independ-
ent cohorts (B58C and FITSA) were investigated for additional
replication, at a nominal level of significance (P-value < 0.05).
For each GWAS and meta-analysis, population stratification
was checked by computing the lambda coefficient of inflation.
The phenotypic variance explained bysingle SNPswas computed
from the mixed-model regression score estimates.
RNA extraction, reverse transcriptase–polymerase chain
reaction (RT-PCR) and real-time quantitative RT-PCR
Total RNA was isolated from postnatal day 5 (P5) mouse cochlea,
extracted with a High Pure RNA Isolation Kit (Roche) and quanti-
fied on a Nanodrop ND-1000 spectrophotometer (NanoDrop Tech-
nologies, Wilmington, DE, USA). Total RNA was used for cDNA
synthesis using the Transcription First Strand cDNA Synthesis
Kit (Roche, Germany). Aliquots (1 μl) of the RT products were sub-
sequently used for PCR amplification. PCR reactions were opti-
mized to 95°C for 2 min, 30 amplification cycles at 95°C for 10 s,
50°C for 15 s, 72°C for 4 s and a final extension of 1 min at 72°C
using Kapa HiFi HotStart ReadyMix PCR kit (Kapa Biosystem,
Cape town, South Africa). Amplified products were resolved on
3% agarose gels and visualized by ethidium bromide staining.
Quantitative Real Time PCR (qRT-PCR) for Slc28a, Pcdh20,
Myo7a and Myo6 genes was performed using standard PCR con-
ditions in a 7900HT Fast Real Time PCR (Life Technologies) with
Power SYBR Green PCRMasterMix (Life Technologies). Gene-spe-
cific primers were designed by using PRIMEREXPRESS software
(Applied Biosystems). The thermal cycling conditions were an
initial denaturation step at 95°C for 10 min, 40 cycles at 95°C for
15 s, 59°C for 1 min and 72°C for 30 s. The experiments were
performed in biological triplicates.
RNA-Seq expression profiling
We retrieved RNA-Seq data from the Shared Harvard Inner-Ear La-
boratory Database (SHIELD), https://shield.hms.harvard.edu/ (43).
Sequencing
Weselected a pool of 48 subjects from the INGI-FVG cohort for se-
quencing the candidate genes. The subjects were divided in four
groups based on their genotypes at the top two associated SNPs.
In particular, following the genetic models of the associations
5662 | Human Molecular Genetics, 2015, Vol. 24, No. 19
detected, the groups consisted of alternative homozygotes ver-
sus reference homozygotes and/or heterozygotes for each allele
(see Results). For the PCDH20 gene, the selection was done ac-
cording to the dominant model of association as follows: (a) 12
carriers of the effect allele of rs78043697 (CC or CT) and (b) 12
homozygotes for the non-effect allele (TT). For the SLC28A3
gene, the selectionwas done under the additivemodel as follows:
(c) 12 homozygotes for the effect allele of rs7032430 (AA) and (d)
12 homozygotes for the non-effect allele (CC). The coding se-
quence and the intron-exon boundaries were analyzed by Sanger
sequencing. A standard PCR was carried out at 60°C, for 35 cycles
using KAPA2G Fast ReadyMix PCR Kit (Kapa Biosystems), accord-
ing to the manufacturer’s protocol. Sequencing was performed
on a 3500Dx Genetic Analyzer (Life Technologies, CA, USA),
using 3.1 Big Dye terminator chemistry (Life Technologies, CA,
USA) according to the manufacturer’s instructions. Primer se-
quences are available upon request.
Supplementary Material
Supplementary Material is available at HMG online.
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